• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS, INC. 1818910 TC3 RP TIBIAL INSERT S2.5,25.0; SIGMA REVISION IMPLANT : KNEE TIBIAL INSERT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS, INC. 1818910 TC3 RP TIBIAL INSERT S2.5,25.0; SIGMA REVISION IMPLANT : KNEE TIBIAL INSERT Back to Search Results
Catalog Number 962337
Device Problem Packaging Problem (3007)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/15/2019
Event Type  malfunction  
Manufacturer Narrative
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
It was reported that the inner portion of the package was damaged.Discovered upon opening.Doe: (b)(6) 2019.
 
Manufacturer Narrative
Product complaint #: (b)(4).Investigation summary: the packaging component associated with the reported event was not returned for evaluation.The investigation could not confirm the reported package damage or draw any conclusions about the root cause without the packaging to examine.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.No device or packaging components associated with the reported event were returned for evaluation.A worldwide complaint database search found no additional reports against the provided tc3 rp tibial insert s2.5,25.0 (product code: 962337, lot: 636350).A search of the depuy nonconformance (nc) quality system found no nc¿s associated with this product/lot combination.Based on the inability to find any nc¿s against the provided product code/lot code combination, it is reasonable to conclude that there are no anomalies with regard to manufacturing that would contribute to the reported event.The investigation could not verify or identify any product contribution to the reported event with the information provided as the reported device and/or packaging components were not returned for evaluation.Based on the inability to confirm the reported event or draw any conclusions about root cause, the need for corrective action was not indicated.Monitor complaints through post market surveillance sep-419.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed, and the investigation may be re-opened as necessary.Update may 20, 2019: received complaint device and packaging materials.The complaint consisted of the product and outer package component for 962337 tc3 rp tibial insert s2.5,25.0, lot code 636350.Examination of the returned outer carton and hard blister cavity did not reveal any damage or manufacturing defects to the blister or blister seal.The complaint subject inner-most packaging (gvf) was not returned for examination.A worldwide complaint database search found no additional reports against the provided product code/lot code combination.A search of the depuy nonconformance (nc) quality system found no nc¿s associated with this product/lot combination.Based on the inability to find any additional reported events or nc¿s against the provided product code/lot code combination, it is reasonable to conclude that there are no anomalies with regard to manufacturing or inspection contained in the device history records that would contribute to the reported event.The investigation could not confirm the reported package damage or draw any conclusions about the root cause without the gvf packaging to examine.Based on the inability to identify product malfunction/error as a contributing factor to the reported package damage, the need for corrective action is not indicated.Complaint trends will be monitored by post market surveillance through sep-419.Depuy synthes considers the investigation closed at this time.Should the additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot: null.Device history batch: null.Device history review: null.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report. .
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Additional narrative: product complaint # (b)(4).Investigation summary: no device or packaging components associated with the reported event were returned for evaluation.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot: null.Device history batch: null.Device history review: null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint (b)(4).Investigation summary : the packaging component associated with the reported event was not returned for evaluation.The investigation could not confirm the reported package damage or draw any conclusions about the root cause without the packaging to examine.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TC3 RP TIBIAL INSERT S2.5,25.0
Type of Device
SIGMA REVISION IMPLANT : KNEE TIBIAL INSERT
Manufacturer (Section D)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic drive
warsaw IN 46582 0988
MDR Report Key8483653
MDR Text Key140932404
Report Number1818910-2019-89780
Device Sequence Number1
Product Code NJL
UDI-Device Identifier10603295242185
UDI-Public10603295242185
Combination Product (y/n)N
PMA/PMN Number
P830055
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup
Report Date 03/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number962337
Device Lot Number636350
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/20/2019
Initial Date Manufacturer Received 03/15/2019
Initial Date FDA Received04/04/2019
Supplement Dates Manufacturer Received05/07/2019
05/17/2019
05/21/2019
Supplement Dates FDA Received05/07/2019
05/27/2019
06/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age83 YR
-
-